发明名称 |
Organometallic compounds for the treatment of cancer |
摘要 |
The present invention relates to novel organometallic compounds for use as a medicine, in particular in photodynamic therapy against various diseases, such as cancer. The compounds comprise a central porphyrin or phtalocyanine backbone to which ligand linkers coordinated to at least one transition metal are attached. Eta-5 or eta-6 arenes further bind to the transition metal. According to a preferred embodiment, the compound is a tetranuclear Ruthenium (+II) complex.
|
申请公布号 |
EP1950217(A1) |
申请公布日期 |
2008.07.30 |
申请号 |
EP20070101258 |
申请日期 |
2007.01.26 |
申请人 |
UNIVERSITE DE NEUCHATEL |
发明人 |
THERRIEN, BRUNO;PADAVATTAN, GOVINDASVAMY;SUESS-FINK, GEORG;ANG, WEE HAN;DYSON, PAUL JOSEPH;JUILLERAT, LUCIENNE |
分类号 |
C07F17/02;A61K31/28;A61P35/00;C07F15/00 |
主分类号 |
C07F17/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|